# FDA recall D-1393-2012

> **Lloyd Inc** · Class II · drug recall initiated 2012-02-03.

## Product

Levothroid (levothyroxine sodium tablets, USP), 50 mcg., packaged in 100-ct. bottles, RX, NDC 0456-1321-01.  Manufactured for Forest Pharmaceuticals, Inc., Subsidiary of Forest Laboratories, Inc., St. Louis, MO, by Lloyd Pharmaceutical, Shenandoah, IA.

## Reason for recall

Subpotent (Single Ingredient Drug): Low assay at the 9-month test interval.

## Distribution

Nationwide and PR.

## Key facts

- **Recall number:** D-1393-2012
- **Recalling firm:** Lloyd Inc
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-02-03
- **Report date:** 2012-07-04
- **Termination date:** 2013-07-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Shenandoah, IA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1393-2012

## Citation

> AI Analytics. FDA recall D-1393-2012. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-1393-2012. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
